Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer.

[1]  T. Brüning,et al.  Chromosomal alterations in exfoliated urothelial cells from bladder cancer cases and healthy men: a prospective screening study , 2014, BMC Cancer.

[2]  Prokar Dasgupta,et al.  Recent advances in the diagnosis and treatment of bladder cancer , 2013, BMC Medicine.

[3]  M. Höglund.  The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles. , 2012, Urologic oncology.

[4]  Laszlo Somogyi,et al.  Automated signal pattern evaluation of a bladder cancer specific multiprobe‐fish assay applying a user‐trainable workstation , 2012, Microscopy research and technique.

[5]  John V Lamont,et al.  The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria , 2012, Cancer.

[6]  W. Marganski,et al.  Digitized microscopy in the diagnosis of bladder cancer , 2011, Cancer cytopathology.

[7]  L. Farkas,et al.  Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[8]  A. Renshaw.  UroVysion, urine cytology, and the College of American Pathologists: where should we go from here? , 2010, Archives of pathology & laboratory medicine.

[9]  Y. Lotan,et al.  Considerations on implementing diagnostic markers into clinical decision making in bladder cancer. , 2010, Urologic oncology.

[10]  J. Bentz,et al.  “FISHing” to detect urinary and other cancers , 2010, Cancer cytopathology.

[11]  Yair Lotan,et al.  Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. , 2009, European urology.

[12]  T. Hajdinjak.  UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. , 2008, Urologic oncology.

[13]  H. Grossman,et al.  Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology , 2008 .

[14]  D. Parkin,et al.  The global burden of urinary bladder cancer , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[15]  M. Knowles.  Bladder cancer subtypes defined by genomic alterations , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[16]  K. Halling,et al.  Fluorescence in situ hybridization in diagnostic cytology. , 2007, Human pathology.

[17]  E. Crawford,et al.  The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer. , 2004, Urologic oncology.

[18]  D. Weisenberger,et al.  Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer , 2003, BJU international.

[19]  J. Jones,et al.  Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. , 2003, The Journal of urology.

[20]  L. Bubendorf,et al.  DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine , 2002, Cancer.

[21]  D. Grönemeyer,et al.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.

[22]  L. Bubendorf,et al.  Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. , 2001, American journal of clinical pathology.

[23]  D J O'Kane,et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.

[24]  R. Jenkins,et al.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.